We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
This protocol describes the analysis of human hepatocarcinoma cells (Hep G2) for lipid peroxidation products such as malondialdehyde (MDA), following treatment with nanoparticle formulations, as part of the in vitro
NCL preclinical characterization cascade (1-2).
